PROSPECTS AND OPPORTUNITIES
Chronic pain treatment as an opportunity for analgesics despite competition from non-pharmacological alternatives
Chronic pain is still a health issue that is receiving little attention within the health and social spheres, despite the fact that some 13 million Italians suffer from it. The elderly are especially susceptible to conditions causing chronic pain, and Italy has one of the oldest populations in the world.
Women’s health focus to drive growth for specifically targeted analgesics
In Italy, awareness of women’s health and female pain is growing, with increased awareness not only of menstrual pain but also of chronic pelvic pain, postnatal pain and pain due to endometriosis, which affects about 15% of Italian women. This represents fertile ground for the development of targeted analgesics that meet the specific needs of this population segment.
Topical analgesics/anaesthetic category to shift to more comfortable formats and better user experience
The full resumption of outdoor activities after the COVID-19 crisis, and the boost that the experiences of the pandemic gave to consumers’ desire to maintain health and wellbeing through regular physical activity will help to maintain the level of attention on topical analgesics that effectively respond to sports-related trauma-type pain. However, given the declining interest in topical analgesics in the patch format, the industry trend will be to invest more in gel and foam formats that are perceived to be more comfortable and pleasant to use.
Delivery:
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
This report comes in PDF with additional info in Excel included.
Overview:
Understand the latest market trends and future growth opportunities for the Analgesics industry in Italy with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Analgesics industry in Italy, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
The Analgesics in Italy report includes:
- Analysis of key supply-side and demand trends
- Detailed segmentation of international and local products
- Historic volume and value sizes, company and brand market shares
- Five year forecasts of market trends and market growth
- Robust and transparent research methodology, conducted in-country
This report answers:
- What is the market size of Analgesics in Italy?
- Which are the leading brands in Analgesics in Italy?
- How are products distributed in Analgesics in Italy?
- How has the regulatory and operating environment for Analgesics changed in Italy?
- How are considerations such as stress, self-medication and shifting consumer lifestyles shaping demand for Analgesics
- How significant are wider health concerns and consumer awareness in determining sales?
- Where is future growth expected to be most dynamic?
Analgesics in Italy - Category analysis
KEY DATA FINDINGS
Unexpectedly short flu season stalls analgesics sales
Ibuprofen's broad appeal fuels growth despite unusual flu season driven by quick release formulations
Topical analgesics/anaesthetic continues to suffer from the poor performance of patches and competition from non-medicated options.
Chronic pain treatment as an opportunity for analgesics despite competition from non-pharmacological alternatives
Women’s health focus to drive growth for specifically targeted analgesics
Topical analgesics/anaesthetic category to shift to more comfortable formats and better user experience
Consumer Health in Italy - Industry Overview
Consumer health in 2024: The big picture
2024 key trends
Competitive landscape
Retailing developments
What next for consumer health?
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
DISCLAIMER
DEFINITIONS
The following categories and subcategories are included:
Analgesics
-
-
- Adult Acetaminophen
- Adult Aspirin
- Adult Combination Products - Analgesics
- Adult Diclofenac
- Adult Dipyrone
- Adult Ibuprofen
- Adult Ketoprofen
- Adult Naproxen
- Adult OTC Triptans
-
- Paediatric Acetaminophen
- Paediatric Aspirin
- Paediatric Combination Products - Analgesics
- Paediatric Dipyrone
- Paediatric Ibuprofen
- Paediatric Naproxen
-
- Acetaminophen
- Aspirin
- Combination Products - Analgesics
- Diclofenac
- Dipyrone
- Ibuprofen
- Ketoprofen
- Naproxen
- OTC Triptans
-
- Topical Analgesics/Anaesthetic
Analgesics
Analgesics cover systemic and topical pain relievers. Products which include a pain-relief ingredient in addition to another core function are excluded (e.g. a sore throat remedy which includes paracetamol is excluded from the analgesics and instead is included in pharyngeal remedies).
See all of our definitionsWhy buy this report?
- Gain competitive intelligence about market leaders
- Track key industry trends, opportunities and threats
- Inform your marketing, brand, strategy and market development, sales and supply functions
This report originates from Passport, our Analgesics research and analysis database.
NEW REPORT GUARANTEE
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!